Literature DB >> 12868506

31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression?

Dan V Iosifescu1, Perry E Renshaw.   

Abstract

In this paper we review studies of brain cellular high-energy phosphate metabolism, as measured by phosphorus-31 magnetic resonance spectroscopy (31P-MRS), in subjects with major depressive disorder (MDD). We also review the literature on the role of thyroid hormones on the cellular high-energy phosphate metabolism in multiple organs. Finally, we review data on the efficacy of thyroid hormones as adjuvant treatment in MDD. The framework established by these findings enables us to hypothesize that dysfunction of brain cellular energy metabolism is a vulnerability factor for MDD, and that correcting cellular energy metabolism (e.g., with thyroid hormones) is a valid therapeutic strategy for improving the symptoms of MDD. We discuss our hypothesis in the context of other current theories on the mechanism of thyroid hormones in MDD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868506     DOI: 10.1080/10673220303959

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  9 in total

1.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

2.  Evidence for a relationship between body mass and energy metabolism in the human brain.

Authors:  André Schmoller; Torben Hass; Olga Strugovshchikova; Uwe H Melchert; Harald G Scholand-Engler; Achim Peters; Ulrich Schweiger; Fritz Hohagen; Kerstin M Oltmanns
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-14       Impact factor: 6.200

3.  Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.

Authors:  Wei-hua Shao; Jian-jun Chen; Song-hua Fan; Yang Lei; Hong-bo Xu; Jian Zhou; Peng-fei Cheng; Yong-tao Yang; Cheng-long Rao; Bo Wu; Hai-peng Liu; Peng Xie
Journal:  OMICS       Date:  2015-07

4.  Hypobaric hypoxia induces depression-like behavior in female Sprague-Dawley rats, but not in males.

Authors:  Shami Kanekar; Olena V Bogdanova; Paul R Olson; Young-Hoon Sung; Kristen E D'Anci; Perry F Renshaw
Journal:  High Alt Med Biol       Date:  2015-03       Impact factor: 1.981

5.  Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder.

Authors:  Douglas G Kondo; Tracy L Hellem; Young-Hoon Sung; Namkug Kim; Eun-Kee Jeong; Kristen K Delmastro; Xianfeng Shi; Perry F Renshaw
Journal:  Depress Res Treat       Date:  2010-10-04

6.  Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.

Authors:  Douglas G Kondo; Lauren N Forrest; Xianfeng Shi; Young-Hoon Sung; Tracy L Hellem; Rebekah S Huber; Perry F Renshaw
Journal:  Amino Acids       Date:  2016-02-23       Impact factor: 3.520

Review 7.  Creatine for the Treatment of Depression.

Authors:  Brent M Kious; Douglas G Kondo; Perry F Renshaw
Journal:  Biomolecules       Date:  2019-08-23

8.  Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans.

Authors:  Kamila Jauch-Chara; Alexia Friedrich; Magdalena Rezmer; Uwe H Melchert; Harald G Scholand-Engler; Manfred Hallschmid; Kerstin M Oltmanns
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

9.  Linking neuronal brain activity to the glucose metabolism.

Authors:  Britta Göbel; Kerstin M Oltmanns; Matthias Chung
Journal:  Theor Biol Med Model       Date:  2013-08-29       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.